SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Abbott India informs about resignation letter of SMP

16 Apr 2025 Evaluate
With reference to its earlier communication dated February 20, 2025, wherein the Company had informed the Stock Exchange regarding resignation of Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy of the Company, effective close of business hours of April 15, 2025, to pursue opportunities outside the Company. Further to the above communication and pursuant to Regulation 30 read with Clause 7C of Para A of Part A of Schedule Ill of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Abbott India has informed that it enclosed, resignation letter of Namita Shah.

The above information is a part of company’s filings submitted to BSE.


Abbott India Share Price

27605.00 943.55 (3.54%)
11-May-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1882.50
Dr. Reddys Lab 1290.55
Cipla 1339.80
Zydus Lifesciences 945.35
Lupin 2254.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×